H19 and neoplasm: To test whether the in vivo tumor growth inhibition activity of H19-DTA-P4-DTA was augmented-than-additive, an additional group of T24P tumor-containing mice was treated with three injections of 25 μg each of single-promoter constructs H19-DTA + P4-DTA in combination.